BioSpace News Archive

A replay of the webcast will be available until February 11th at midnight eastern time.

BD announced that it will conduct a live webcast of its first fiscal quarter 2020 earnings conference call on Thursday, February 6, 2020, at 8:00 a.m.

Today announced it will report its financial results for the fourth quarter and year ended December 31, 2019 after the stock market closes on Wednesday, March 11, 2020.

Q4 2019 DecisionDx-Melanoma test report volume increased 37% compared to Q4 2018

ADC Therapeutics SA, a clinical-stage oncology-focused biotechnology company pioneering the development and commercialization of highly potent antibody drug conjugates (ADCs) for patients suffering from hematological malignancies and solid tumors, today announced positive results from the pivotal 145-patient Phase 2 clinical trial of loncastuximab tesirine (ADCT-402)

Galen, a member of the Almac Group and privately owned global pharmaceutical sales and marketing company, today announced the completion of a multi-million pound acquisition and takeover of boutique healthcare company, POA Pharma.

Gilead Sciences, Inc. announced that the company has licensed The Rockefeller University’s portfolio of broadly neutralizing antibodies against HIV, including the two clinical-stage agents 3BNC117 and 10-1074.

Gencove’s flagship product is its low-pass whole genome sequencing platform, which is a technology that has the potential to more accurately assess the genetic potential of an animal earlier in its life.

New five-year, multi-target alliance aims to translate first-in-class science and drug discovery into new drugs for polycystic ovary syndrome

CareCentrix, the leading provider of home-based post-acute care solutions, happily announces that it has been recognized by independent analysts at the Great Place to Work Institute with a certification as a 2019-2020 Great Place to Work.